The invention provides polypeptide fragments derived from TgAMA-1, nucleic acids that encode the polypeptide fragments, and TgAMA-binding polypeptides such as antibodies. Methods for using the polypeptide and nucleic acid molecules to produce vaccines are also provided. In addition the invention provides methods involving use of the polypeptides, nucleic acids, and binding polypeptides, such as antibodies, for the prevention and treatment of Toxoplasmosis.
本发明提供了源自 Tg
AMA-1 的
多肽片段、编码
多肽片段的核酸以及 TgAMA 结合
多肽(如
抗体)。本发明还提供了使用
多肽和核酸分子生产疫苗的方法。此外,本发明还提供了使用
多肽、核酸和结合
多肽(如
抗体)预防和治疗弓形虫病的方法。